Cargando…
Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
BACKGROUND: COVID-19 has brought an unprecedented challenge to healthcare services. The authors’ COVID-adapted pathway for suspected bowel cancer combines two quantitative faecal immunochemical tests (qFITs) with a standard CT scan with oral preparation (CT mini-prep). The aim of this study was to e...
Autores principales: | Maeda, Y, Gray, E, Figueroa, J D, Hall, P S, Weller, D, Dunlop, M G, Din, F V N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259497/ https://www.ncbi.nlm.nih.gov/pubmed/34228096 http://dx.doi.org/10.1093/bjsopen/zrab056 |
Ejemplares similares
-
Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, A D, et al.
Publicado: (2023) -
Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, Adam D, et al.
Publicado: (2023) -
Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017) -
Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020) -
Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)